-
公开(公告)号:AR077510A1
公开(公告)日:2011-08-31
申请号:ARP100102775
申请日:2010-07-30
Applicant: SERVIER LAB
Inventor: FEJES IMRE , BURBRIDGE MICHAEL , ORTUNO JEAN-CLAUDE , HICKMAN JOHN , LACOSTE JEAN-MICHEL , PIERRE ALAIN , CORDI ALEXIS
IPC: C07D413/14 , C07D417/14 , C07D471/08 , A61K31/422 , A61K31/427 , A61K31/439 , A61P35/00 , A61P35/04
Abstract: Su empleo en medicamentos para el tratamiento del cáncer. Reivindicacion 1: Compuestos de formula (1): en la que ò m representa 1 o 2, ò n representa 1 o 2, ò A representa un grupo pirrolilo no sustituido o sustituido con 1 a 3 grupos alquilo (C1-6) lineal o ramificado, ò X representa el grupo C(O), S(O) o SO2, ò R1 y R2, idénticos o diferentes, representan cada uno un grupo alquilo (C1-6) lineal o ramificado, o R1 y R2 forman junto con el átomo de nitrogeno al que están unidos un grupo heterocíclico, ò R3 y R4 forman junto con los átomos a los que están unidos un grupo heterocíclico, ò R5 representa un átomo de hidrogeno o un grupo alquilo (C1-6) lineal o ramificado, ò R6 representa un átomo de hidrogeno o un átomo de halogeno, entendiéndose que: - por ôgrupo heterocíclicoö, se entiende un grupo mono o bicíclico que puede contener de 5 a 8 vértices, que puede contener de uno a tres heteroátomos elegidos entre nitrogeno, oxigeno y azufre, y que puede contener una o varias insaturaciones, pudiendo estar el grupo heterociclico así definido no sustituido o sustituido con uno o varios grupos elegidos entre alquilo (C1-6) lineal o ramificado, alquenilo (C1-6) lineal o ramificado, oxo, hidroxi, alcoxi (C1-6) lineal o ramificado, arilo, arilalquilo, y arilalquenilo, - por ôariloö, se entiende el grupo fenilo no sustituido o sustituido con uno o varios grupos elegidos entre los átomos de halogeno y los grupos alquilo (C1-6) lineal o ramificado, - el siglo X significa que la doble enlace tiene configuracion Z o E, sus isomeros opticos y geométricos, así como sus sales de adicion a un ácido o a una base farmacéuticamente aceptable.
-
92.
公开(公告)号:ZA201005424B
公开(公告)日:2011-04-28
申请号:ZA201005424
申请日:2010-07-29
Applicant: SERVIER LAB
Inventor: BURBRIDGE MICHAEL , FEJES IMRE , LACOSTE JEAN-MICHEL , ORTUNO JEAN-CLAUDE , CORDI ALEXIS , HICKMAN JOHN , PIERRE ALAIN
Abstract: Dihydroindolone derivatives (I) and their optical and geometric isomers, or addition salts with an acid or base are new. Dihydroindolone derivatives of formula (I) and their optical and geometric isomers, or addition salts with an acid or base are new. m : 1 or 2; n : 1 or 2; A : a pyrrolyl group optionally substituted by 1-3 groups of 1-6C alkyl; X : C(O), S(O) or SO 2; either R 1>, R 2> : 1-6C alkyl; or NR 1>R 2> : a heterocyclic group; R 3>R 4> : a heterocyclic group; R 5> : H or 1-6C alkyl; and R 6> : H or halo, where the heterocyclic group is a mono or bicyclic 5-8 membered group (optionally containing one to three heteroatoms of N, O or S, and one or more unsaturations, and optionally substituted by one or more 1-6C alkyl, 1-6C alkenyl, oxo, hydroxy, 1-6C alkoxy, aryl, arylalkyl or arylalkenyl), the aryl is phenyl group optionally substituted by one or more halo or 1-6C alkyl, and X represents the double bond, which is in configuration is Z or E. Independent claims are included for: (1) the preparations of (I); and (2) combination comprising (I) with an anticancer agent comprising genotoxic agents, mitotic poisons, antimetabolites, proteasome inhibitors or kinase inhibitors. [Image] ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
-
公开(公告)号:AU2010203305A1
公开(公告)日:2011-02-24
申请号:AU2010203305
申请日:2010-07-23
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN-CLAUDE , CORDI ALEXIS , LACOSTE JEAN-MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN
IPC: C07D417/14 , A61K31/4045 , A61P35/00 , C07D403/14 , C07D413/14
Abstract: Dihydroindolone derivatives (I) and their optical and geometric isomers, or addition salts with an acid or base are new. Dihydroindolone derivatives of formula (I) and their optical and geometric isomers, or addition salts with an acid or base are new. m : 1 or 2; n : 1 or 2; A : a pyrrolyl group optionally substituted by 1-3 groups of 1-6C alkyl; X : C(O), S(O) or SO 2; either R 1>, R 2> : 1-6C alkyl; or NR 1>R 2> : a heterocyclic group; R 3>R 4> : a heterocyclic group; R 5> : H or 1-6C alkyl; and R 6> : H or halo, where the heterocyclic group is a mono or bicyclic 5-8 membered group (optionally containing one to three heteroatoms of N, O or S, and one or more unsaturations, and optionally substituted by one or more 1-6C alkyl, 1-6C alkenyl, oxo, hydroxy, 1-6C alkoxy, aryl, arylalkyl or arylalkenyl), the aryl is phenyl group optionally substituted by one or more halo or 1-6C alkyl, and X represents the double bond, which is in configuration is Z or E. Independent claims are included for: (1) the preparations of (I); and (2) combination comprising (I) with an anticancer agent comprising genotoxic agents, mitotic poisons, antimetabolites, proteasome inhibitors or kinase inhibitors. [Image] ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
-
公开(公告)号:FR2948940A1
公开(公告)日:2011-02-11
申请号:FR0903839
申请日:2009-08-04
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN CLAUDE , CORDI ALEX , LACOSTE JEAN MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN
IPC: C07D413/14 , A61K31/5377 , A61P35/00 , C07D207/323 , C07D209/34 , C07D233/72 , C07D263/22 , C07D295/12
Abstract: Composés de formule (I) : dans laquelle : ▪ m et n représentent 1 ou 2, ▪ A représente un groupement pyrrolyle, ▪ X représente le groupement C(O), S(O) ou SO ▪ R et R représentent un groupement alkyle, ou forment ensemble avec l'atome d'azote qui les porte un groupement hétérocyclique, ▪ R et R forment ensemble avec les atomes qui les portent un groupement hétérocyclique, ▪ R représente un atome d'hydrogène ou un groupement alkyle, ▪ R représente un atome d'hydrogène ou un atome d'halogène,
-
公开(公告)号:CA2710224A1
公开(公告)日:2011-02-04
申请号:CA2710224
申请日:2010-07-28
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN-CLAUDE , CORDI ALEXIS , LACOSTE JEAN-MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN
IPC: C07D417/14 , A61K31/5377 , A61P35/00
Abstract: Composés de formule (I): (voir formula I) dans laquelle : ~ m et n représentent 1 ou 2, ~ A représente un groupement pyrrolyle, ~ X représente le groupement C(O), S(O) ou SO2, ~ R1 et R2 représentent un groupement alkyle, ou forment ensemble avec l'atome d'azote qui les porte un groupement hétérocyclique, ~ R3 et R4 forment ensemble avec les atomes qui les portent un groupement hétérocyclique, ~ R5 représente un atome d'hydrogène ou un groupement alkyle, ~ R6 représente un atome d'hydrogène ou un atome d'halogène, Médicaments.
-
公开(公告)号:MD4793B1
公开(公告)日:2022-02-28
申请号:MD20160018
申请日:2014-07-22
Applicant: SERVIER LAB , VERNALIS R&D LTD
Inventor: CHEN I-JEN , DAVIDSON JAMES EDWARD PAUL , MURRAY JAMES BROOKE , WALMSLEY CLAIRE , DODSWORTH MARK , MEISSNER JOHANNES W G , BROUGH PAUL , FEJES IMRE , TATAI JANOS , NYERGES MIKLOS , KOTSCHY ANDRAS , SZLAVIK ZOLTAN , GENESTE OLIVIER , LE TIRAN ARNAUD , LE DIGUARHER THIERRY , HENLIN JEAN-MICHEL , STARCK JÉRÔME-BENOÎT , GUILLOUZIC ANNE-FRANÇOISE , DE NANTEUIL GUILLAUME
IPC: C07D401/14 , A61K31/4709 , A61K31/4725 , A61P35/00 , A61P37/00 , C07D401/10 , C07D405/14 , C07D409/14 , C07D471/04
Abstract: Invenţia se referă la compuşi noi de izoindolină sau izochinolină, la un procedeu de obţinere a lor şi la compoziţii farmaceutice care le conţin. Prezenta invenţie se referă, în special, la compuşii cu formula (I):unde substituenţii sunt definiţi în descrierea invenţiei. Compuşii, conform invenţiei, au proprietăţi pro-apoptotice, fapt ce permite utilizarea lor în patologii care implică un defect în apoptoză, cum ar fi, de exemplu, în tratamentul cancerului, bolilor autoimune şi bolilor sistemului imunitar.
-
公开(公告)号:ECSP20023535A
公开(公告)日:2020-05-29
申请号:ECDI202023535
申请日:2020-04-24
Applicant: VERNALIS R D LTD , SERVIER LAB
Inventor: LE TIRAN ARNAUD , NYERGES MIKLOS , LIGETI MELINDA , FEJES IMRE , STARCK JEROME-BENOIT , ORTUNO JEAN-CLAUDE , CHEN I-JEN , DURAND DIDIER
IPC: A61K31/407 , A61P35/00 , C07D498/22
Abstract: Compuesto de fórmula (I): (VER FORMULA EN MEMORIA TECNICA) en la que A1, A2, Ra, Rb, Rc, Rd, R3, R4, X, Y y G son tales como se han definido en la descripción, y su utilización en la fabricación de medicamentos.
-
公开(公告)号:PL3024826T3
公开(公告)日:2019-05-31
申请号:PL14741648
申请日:2014-07-22
Applicant: SERVIER LAB , VERNALIS R&D LTD
Inventor: DAVIDSON JAMES EDWARD PAUL , MURRAY JAMES BROOKE , CHEN I-JEN , WALMSLEY CLAIRE , DODSWORTH MARK , MEISSNER JOHANNES W G , BROUGH PAUL , FEJES IMRE , TATAI JANOS , NYERGES MIKLOS , KOTSCHY ANDRAS , SZLAVIK ZOLTAN , GENESTE OLIVIER , LE TIRAN ARNAUD , LE DIGUARHER THIERRY , HENLIN JEAN-MICHEL , STARCK JÉRÔME-BENOÎT , GUILLOUZIC ANNE-FRANÇOISE , DE NANTEUIL GUILLAUME
IPC: C07D401/14 , A61K31/4709 , A61K31/4725 , A61P35/00 , A61P37/00 , C07D401/10 , C07D405/14 , C07D409/14 , C07D471/04
-
公开(公告)号:NZ716155A
公开(公告)日:2019-05-31
申请号:NZ71615514
申请日:2014-07-22
Applicant: SERVIER LAB , VERNALIS R&D LTD
Inventor: STARCK JÉRÔME-BENOÎT , HENLIN JEAN-MICHEL , DAVIDSON JAMES EDWARD PAUL , MURRAY JAMES BROOKE , LE TIRAN ARNAUD , DE NANTEUIL GUILLAUME , LE DIGUARHER THIERRY , WALMSLEY CLAIRE , CHEN I-JEN , DODSWORTH MARK , MEISSNER JOHANNES , BROUGH PAUL , FEJES IMRE , TATAI JANOS , NYERGES MIKLOS , KOTSCHY ANDRAS , SZLAVIK ZOLTAN , GENESTE OLIVIER , GUILLOUZIC ANNE-FRANÇOISE
IPC: C07D401/14 , A61K31/435 , A61P35/00 , A61P37/00 , C07D413/14
Abstract: Compounds of formula (I): (I) wherein Het, R3, R4, R5, R7, R8, R9, T, p, p’, q, and q’ are as defined in the description are pro-apoptotic agents useful in the treatment of cancers and of auto-immune and immune system diseases.
-
100.
公开(公告)号:HRP20190277T1
公开(公告)日:2019-04-05
申请号:HRP20190277
申请日:2019-02-12
Applicant: SERVIER LAB , VERNALIS R&D LTD
Inventor: DAVIDSON JAMES EDWARD PAUL , MURRAY JAMES BROOKE , CHEN I-JEN , WALMSLEY CLAIRE , DODSWORTH MARK , MEISSNER JOHANNES W G , BROUGH PAUL , FEJES IMRE , TATAI JANOS , NYERGES MIKLOS , KOTSCHY ANDRAS , SZLAVIK ZOLTAN , GENESTE OLIVIER , LE TIRAN ARNAUD , LE DIGUARHER THIERRY , HENLIN JEAN-MICHEL , STARCK JÉRÔME-BENOÎT , GUILLOUZIC ANNE-FRANÇOISE , DE NANTEUIL GUILLAUME
IPC: C07D401/14 , A61K31/4709 , A61K31/4725 , A61P35/00 , A61P37/00 , C07D401/10 , C07D405/14 , C07D409/14 , C07D471/04
-
-
-
-
-
-
-
-
-